Prostate Tumors Clinical Trial
Official title:
Technical Success, Safety, and Short and Long-term Efficacy for MR-Guided Cryoablation of Prostate Bed Recurrences
The purpose of this research is to see if MR-guided cryoablation can effectively treat prostate tumor recurrences.
Status | Recruiting |
Enrollment | 200 |
Est. completion date | October 2024 |
Est. primary completion date | October 2024 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 30 Years to 100 Years |
Eligibility | Inclusion Criteria: - Patients with "biopsy proven" soft tissue tumor recurrences of prostate fossa - Surgery is not a desirable alternative therapy at the time of enrollment - Radiation therapy has failed or not indicated or can be safely postponed - Tumor size is < 5 cm at its largest diameter - Tumor does not encompass the rectal wall or external urethral sphincter - Patient is able to undergo MRI Exclusion Criteria: - N/A |
Country | Name | City | State |
---|---|---|---|
United States | Mayo Clinic in Rochester | Rochester | Minnesota |
Lead Sponsor | Collaborator |
---|---|
Mayo Clinic |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluation of target lesion at 3-6, 12, 24, and 36 month imaging follow-up | 3 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT01743638 -
MR-Guided Laser Ablation of Prostate Bed Recurrences
|
N/A |